DK167192B1 - Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer - Google Patents
Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer Download PDFInfo
- Publication number
- DK167192B1 DK167192B1 DK426386A DK426386A DK167192B1 DK 167192 B1 DK167192 B1 DK 167192B1 DK 426386 A DK426386 A DK 426386A DK 426386 A DK426386 A DK 426386A DK 167192 B1 DK167192 B1 DK 167192B1
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- sds
- solution
- approx
- inclusion bodies
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 110
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 107
- 210000003000 inclusion body Anatomy 0.000 title claims abstract description 48
- 238000000034 method Methods 0.000 title claims description 43
- 230000003213 activating effect Effects 0.000 title claims description 5
- 238000004140 cleaning Methods 0.000 title 1
- 239000011347 resin Substances 0.000 claims abstract description 28
- 229920005989 resin Polymers 0.000 claims abstract description 28
- 239000012460 protein solution Substances 0.000 claims abstract description 20
- 244000005700 microbiome Species 0.000 claims abstract description 13
- 239000003957 anion exchange resin Substances 0.000 claims abstract description 8
- 230000003381 solubilizing effect Effects 0.000 claims abstract 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 63
- 108010006025 bovine growth hormone Proteins 0.000 claims description 21
- 150000002500 ions Chemical class 0.000 claims description 21
- 239000000243 solution Substances 0.000 claims description 21
- 239000000122 growth hormone Substances 0.000 claims description 13
- 238000000502 dialysis Methods 0.000 claims description 12
- 108010051696 Growth Hormone Proteins 0.000 claims description 11
- 102000018997 Growth Hormone Human genes 0.000 claims description 11
- 238000004587 chromatography analysis Methods 0.000 claims description 10
- 239000007853 buffer solution Substances 0.000 claims description 9
- 239000008366 buffered solution Substances 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 2
- 230000008014 freezing Effects 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 10
- 238000000746 purification Methods 0.000 abstract description 11
- 230000004913 activation Effects 0.000 abstract description 7
- 210000004027 cell Anatomy 0.000 description 24
- 239000000872 buffer Substances 0.000 description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 14
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 11
- 229960000789 guanidine hydrochloride Drugs 0.000 description 11
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 11
- 239000000463 material Substances 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 8
- 238000001994 activation Methods 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 description 6
- 239000012467 final product Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000000108 ultra-filtration Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 239000003398 denaturant Substances 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- -1 SDS ions Chemical class 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 229940031098 ethanolamine Drugs 0.000 description 3
- 238000004255 ion exchange chromatography Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 241001131785 Escherichia coli HB101 Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- 108010034634 Repressor Proteins Proteins 0.000 description 2
- 102000009661 Repressor Proteins Human genes 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000005349 anion exchange Methods 0.000 description 2
- 238000005571 anion exchange chromatography Methods 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229960004198 guanidine Drugs 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000001742 protein purification Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000702189 Escherichia virus Mu Species 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000012614 Q-Sepharose Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- DZBUGLKDJFMEHC-UHFFFAOYSA-N benzoquinolinylidene Natural products C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- HFNQLYDPNAZRCH-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O.OC(O)=O HFNQLYDPNAZRCH-UHFFFAOYSA-N 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011027 product recovery Methods 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 108020005087 unfolded proteins Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77317485 | 1985-09-06 | ||
| US06/773,174 US4677196A (en) | 1985-09-06 | 1985-09-06 | Purification and activation of proteins from insoluble inclusion bodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK426386D0 DK426386D0 (da) | 1986-09-05 |
| DK426386A DK426386A (da) | 1987-03-07 |
| DK167192B1 true DK167192B1 (da) | 1993-09-13 |
Family
ID=25097436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK426386A DK167192B1 (da) | 1985-09-06 | 1986-09-05 | Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4677196A (de) |
| EP (1) | EP0218374B1 (de) |
| JP (1) | JPH082313B2 (de) |
| AT (1) | ATE73138T1 (de) |
| CA (1) | CA1267496A (de) |
| DE (1) | DE3684078D1 (de) |
| DK (1) | DK167192B1 (de) |
| IE (1) | IE60644B1 (de) |
| IL (1) | IL79957A (de) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
| US5792450A (en) * | 1985-02-05 | 1998-08-11 | Chiron Corporation | Purified human CSF-1 |
| US4766224A (en) * | 1985-08-19 | 1988-08-23 | International Minerals & Chemical Corp. | Purification and activation of proteins from insoluble inclusion bodies |
| US4929700A (en) * | 1987-04-16 | 1990-05-29 | Cetus Corporation | Production of purified, biologically active, bacterially produced recombinant human CSF-1 |
| CA1339757C (en) * | 1987-04-16 | 1998-03-17 | Robert F. Halenbeck | Production of purified biologically active, bacterially produced recombinant human csf-1 |
| CA1305285C (en) * | 1987-04-21 | 1992-07-14 | Malcolm Roy Brandon | Production of proteins in active forms |
| US5162507A (en) * | 1987-05-11 | 1992-11-10 | Cetus Corporation | Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms |
| US4931543A (en) * | 1987-05-11 | 1990-06-05 | Cetus Corporation | Process for recovering microbially produced interleukin-2 |
| US4801691A (en) * | 1987-05-15 | 1989-01-31 | International Minerals & Chemical Corp. | Method for removing sodium dodecyl sulfate from sodium dodecyl sulfate solubilized protein solutions |
| AU609824B2 (en) * | 1987-06-15 | 1991-05-09 | Southern Cross Biotech Pty Ltd. | Production of proteins in active forms |
| US4981952A (en) * | 1988-10-04 | 1991-01-01 | Eli Lilly And Company | Method for the purification of vitamin K-dependent proteins |
| US5094960A (en) * | 1988-10-07 | 1992-03-10 | New York Blood Center, Inc. | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography |
| ATE114668T1 (de) * | 1988-10-26 | 1994-12-15 | American Cyanamid Co | Verfahren zur verringerung des aggregatinhaltes in wachstumshormonen gleichenden stoffen. |
| GB8825183D0 (en) * | 1988-10-27 | 1988-11-30 | Atomic Energy Authority Uk | Recovery of substances |
| US5064943A (en) * | 1988-12-16 | 1991-11-12 | American Cyanamid Company | Method for solubilization and naturation of somatotropin |
| US5101018A (en) * | 1989-06-12 | 1992-03-31 | International Minerals & Chemical Corp. | Method for recovering recombinant proteins |
| US4975529A (en) * | 1989-08-18 | 1990-12-04 | Monsanto Company | Method of folding somatotropins |
| US5047511A (en) * | 1989-08-28 | 1991-09-10 | Pitman-Moore, Inc. | Method for recovering recombinant proteins |
| US5204256A (en) * | 1989-09-06 | 1993-04-20 | Behringwerke Aktiengesellschaft | Process for the purification of plasminogen activator inhibitor 2 (pai-2) |
| DK580789D0 (da) * | 1989-11-20 | 1989-11-20 | Novo Nordisk As | Fremgangsmaade til oprensning af polypeptider |
| US5605691A (en) * | 1992-09-17 | 1997-02-25 | Ophidian Pharmaceuticals, Inc. | Immunologically active proteins from inclusion bodies |
| US5563057A (en) * | 1994-10-31 | 1996-10-08 | Wisconsin Alumni Research Foundation | Method for refolding misfolded enzymes with detergent and cyclodextrin |
| US5861372A (en) * | 1996-02-22 | 1999-01-19 | The Children's Medical Center Corporation | Aggregate angiostatin and method of use |
| JPH11509551A (ja) * | 1995-07-21 | 1999-08-24 | アムジエン・インコーポレーテツド | 蛋白質を塩から分離することのできる連続静止相を用いてバッファー交換により蛋白質を巻き戻す方法 |
| US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| KR100392780B1 (ko) * | 1996-12-04 | 2003-11-01 | 주식회사 엘지생명과학 | 대장균에서 발현된 세포외 신호조절 단백질카이네이즈-2의 정제방법 |
| ZA9711733B (en) * | 1996-12-31 | 1998-07-01 | Monsanto Co | Method for solubilization and naturation of somatotropins |
| ES2308800T3 (es) * | 1997-01-08 | 2008-12-01 | Invitrogen Corporation | Metodos para la produccion de proteinas. |
| US7153943B2 (en) | 1997-07-14 | 2006-12-26 | Bolder Biotechnology, Inc. | Derivatives of growth hormone and related proteins, and methods of use thereof |
| DK1095056T3 (da) * | 1998-07-09 | 2007-04-23 | Barofold Inc | Höjtryksrefoldning af proteinaggregater og inklusionslegemer |
| DE60129432T2 (de) | 2000-05-16 | 2008-04-17 | Bolder Biotechnology, Inc., Louisville | Verfahren zur rückfaltung von proteinen mit freien cysteinresten |
| EP1434789B1 (de) * | 2000-10-31 | 2008-03-26 | BaroFold, Inc. | Verbesserter zerfall und rückfaltung von proteinen mittels hohen drucks |
| WO2003102013A2 (en) | 2001-02-23 | 2003-12-11 | Gonzalez-Villasenor Lucia Iren | Methods and compositions for production of recombinant peptides |
| US20070036258A1 (en) * | 2003-09-30 | 2007-02-15 | Osamu Ito | Process for producing radioactive fluorine compound |
| WO2008042495A2 (en) | 2006-07-21 | 2008-04-10 | Life Technologies Corporation | Sharply resolving labeled protein molecular weight standards |
| US20080161242A1 (en) * | 2006-09-15 | 2008-07-03 | Randolph Theodore W | High pressure treatment of proteins for reduced immunogenicity |
| US8617531B2 (en) | 2006-12-14 | 2013-12-31 | Bolder Biotechnology, Inc. | Methods of making proteins and peptides containing a single free cysteine |
| WO2011022771A1 (en) * | 2009-08-26 | 2011-03-03 | Commonwealth Scientific Industrial Research Organisation | Processes for producing silk dope |
| EP3344651B1 (de) | 2015-09-02 | 2022-03-02 | Merck Sharp & Dohme Corp. | Verfahren zur gewinnung von insulin mit korrekt geformten disulfidbindungen |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4426323A (en) * | 1980-01-10 | 1984-01-17 | Ionics, Incorporated | Selected recovery of proteins from fermentation broths |
| US4511502A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| US4511503A (en) * | 1982-12-22 | 1985-04-16 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
| IE56372B1 (en) * | 1982-12-22 | 1991-07-03 | Genentech Inc | Microbially produced rennet methods for its production and plasmids used for its production |
| US4518526A (en) * | 1982-12-22 | 1985-05-21 | Genentech, Inc. | Purification and activity assurance of precipitated heterologous proteins |
-
1985
- 1985-09-06 US US06/773,174 patent/US4677196A/en not_active Expired - Lifetime
-
1986
- 1986-09-05 JP JP61208077A patent/JPH082313B2/ja not_active Expired - Lifetime
- 1986-09-05 IL IL79957A patent/IL79957A/xx not_active IP Right Cessation
- 1986-09-05 DE DE8686306871T patent/DE3684078D1/de not_active Expired - Fee Related
- 1986-09-05 DK DK426386A patent/DK167192B1/da not_active IP Right Cessation
- 1986-09-05 AT AT86306871T patent/ATE73138T1/de not_active IP Right Cessation
- 1986-09-05 IE IE237086A patent/IE60644B1/en not_active IP Right Cessation
- 1986-09-05 EP EP86306871A patent/EP0218374B1/de not_active Expired - Lifetime
- 1986-09-05 CA CA000517604A patent/CA1267496A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| ATE73138T1 (de) | 1992-03-15 |
| IE60644B1 (en) | 1994-08-10 |
| JPS6269998A (ja) | 1987-03-31 |
| IL79957A0 (en) | 1986-12-31 |
| US4677196A (en) | 1987-06-30 |
| EP0218374A1 (de) | 1987-04-15 |
| JPH082313B2 (ja) | 1996-01-17 |
| CA1267496C (en) | 1990-04-03 |
| EP0218374B1 (de) | 1992-03-04 |
| CA1267496A (en) | 1990-04-03 |
| IE862370L (en) | 1987-03-06 |
| DK426386A (da) | 1987-03-07 |
| IL79957A (en) | 1991-08-16 |
| DE3684078D1 (de) | 1992-04-09 |
| DK426386D0 (da) | 1986-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK167192B1 (da) | Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer | |
| EP0212960B1 (de) | Reinigung und Aktivierung von Proteinen aus unlöslichen Einschlussteilchen | |
| CA1267497A (en) | Protein recovery | |
| AU596153B2 (en) | Process of recovering microbially produced recombinant ricin toxin a chain | |
| EP0114506B1 (de) | Methoden zur Reinigung und Reaktivierung von gefällten heterologen Proteinen | |
| US4511502A (en) | Purification and activity assurance of precipitated heterologous proteins | |
| US4512922A (en) | Purification and activity assurance of precipitated heterologous proteins | |
| US4518526A (en) | Purification and activity assurance of precipitated heterologous proteins | |
| US4599197A (en) | Purification and activity assurance of precipitated heterologous proteins | |
| JP5291137B2 (ja) | ８より上または５未満のｐＩを有するペプチドを産生するための方法 | |
| KR960003548B1 (ko) | 생물활성을 갖는 모노머성 성장호르몬의 분리방법 | |
| JPH08510762A (ja) | 塩基性線維芽細胞成長因子の精製プロセス | |
| US20160200792A1 (en) | Purification Process for PTH | |
| CN107400169B (zh) | 一种肿瘤血管阻断剂融合蛋白的纯化方法 | |
| US6121421A (en) | Methods for isolating recombinant β-casein | |
| KR950004013B1 (ko) | 대장균에서 발현된 소 성장 호르몬의 정제 방법 | |
| EP0866862A1 (de) | Prozess für die reinigung von rekombinanten interleukin 8 | |
| CN116063561A (zh) | 一种重组μ-芋螺毒肽及其制备方法 | |
| RU2123010C1 (ru) | Способ получения рекомбинантного интерферона-альфа-2 из нерастворимых тел включения | |
| JPH02255697A (ja) | 融合タンパク質の分離精製方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |